Peter Jenkins - CardieX Independent Non-Executive Director

Director

Mr. Peter R. Jenkins DSc has resigned as Independent NonExecutive Director of AtCor Medical Holdings Limited. effective 13 November 2015. He has served on the AtCor Groups Board since 2000 including 4 years as chairman. He is a Consultant to Colonial First State Private Equity until his retirement in December 2005. Previously he had over 30 years experience in the pharmaceutical and medical diagnostics industry.
Age 78
Phone61 2 9874 8761
Webhttp://cardiex.com

CardieX Management Efficiency

The company has return on total asset (ROA) of (16.43) % which means that it has lost $16.43 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (48.97) %, meaning that it generated substantial loss on money invested by shareholders. CardieX's management efficiency ratios could be used to measure how well CardieX manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 1.7 M in total debt with debt to equity ratio (D/E) of 0.24, which may suggest the company is not taking enough advantage from borrowing. CardieX Limited has a current ratio of 1.67, which is within standard range for the sector. Debt can assist CardieX until it has trouble settling it off, either with new capital or with free cash flow. So, CardieX's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CardieX Limited sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CardieX to invest in growth at high rates of return. When we think about CardieX's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Franklin MillerMerit Medical Systems
76
Patrick HanleyOld Dominion Freight
73
David LiuMerit Medical Systems
43
Michael WrayOld Dominion Freight
57
Elliott BisnowLindblad Expeditions Holdings
32
Katharine ReynoldsLindblad Expeditions Holdings
N/A
Brian SternHNI Corp
71
Dirk JungeLB Foster
69
Scott AndersonMerit Medical Systems
70
Lawrence CalcanoLindblad Expeditions Holdings
53
Robert PurgasonLB Foster
62
Dyson DrydenLindblad Expeditions Holdings
42
James JenkinsHNI Corp
69
Richard DonaldsonLindblad Expeditions Holdings
56
Larry PorcellatoHNI Corp
62
Jill AndersonMerit Medical Systems
58
Cheryl FrancisHNI Corp
67
Diane OwenLB Foster
62
John KasardaOld Dominion Freight
72
John FaheyLindblad Expeditions Holdings
66
Nolan KarrasMerit Medical Systems
72
CardieX Limited designs, manufactures, and markets medical devices for use in cardiovascular health management in the Americas, Europe, and the Asia Pacific. CardieX Limited was founded in 1994 and is headquartered in Sydney, Australia. Cardiex is traded on OTC Exchange in the United States. CardieX Limited [AMDHF] is traded as part of a regulated electronic over-the-counter service offered by the NASD.

Management Performance

CardieX Limited Leadership Team

Elected by the shareholders, the CardieX's board of directors comprises two types of representatives: CardieX inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CardieX. The board's role is to monitor CardieX's management team and ensure that shareholders' interests are well served. CardieX's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CardieX's outside directors are responsible for providing unbiased perspectives on the board's policies.
Rhonda Welch, Vice President of Global Marketing
David Brookes, Independent Non-Executive Director
Mark Harding, VP of Global Marketing and International Sales - Atcor Medical Pty Ltd
Niall Cairns, Non-Executive Director
Chris Dax, Vice President - Operations
Peter Jenkins, Independent Non-Executive Director
Craig Cooper, CEO, Executive Director
Duncan Ross, CEO, Managing Director, Executive Director
Randall Nelson, Independent Non-Executive Director
Douglas Kurschinski, Sr. VP of Atcor Medical Inc and General Manager of Atcor Medical Inc
Michael ORourke, Non-Executive Director
Donal ODwyer, Independent Non-Executive Chairman of the Board
Peter Manley, CFO, Company Secretary

CardieX Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CardieX a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as various price indices.
Note that the CardieX Limited information on this page should be used as a complementary analysis to other CardieX's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Consideration for investing in CardieX OTC Stock

If you are still planning to invest in CardieX Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CardieX's history and understand the potential risks before investing.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
CEOs Directory
Screen CEOs from public companies around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes